Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells

Leukemia

Volumn 11, Issue 5, 1997, Pages 723-728

  Margolin, K A ^a   Wright, C ^a   Forman, S J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Bone marrow; Effector cells; Hematopoiesis; IL 2

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; INTERLEUKIN 2;

ACUTE LEUKEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; BONE MARROW PURGING; BREAST CANCER; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DRUG RESISTANCE; HEMATOPOIESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; LUNG CANCER; LYMPHOKINE ACTIVATED KILLER CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; SOLID TUMOR; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 0030913472     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400646     Document Type: Article

References (9)

1. Rosenberg SA. Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2. In: DeVita Jr VT, Hellman S, Rosenberg SA (eds). Important Advances in Oncology. JB Lippincott: Philadelphia, 1986, pp 55-91.
2. Foa R. Does interleukin-2 have a role in the management of acute leukemia? J Clin Oncol 1993; 11: 1817-1825.
3. Sznol M, Parkinson DR. Interleukin-2 in therapy of hematologic malignancies. Blood 1994; 83: 2020-2022.
4. Dawson MM, Johnston D, Taylor GM, Moore M. Lymphokine activated killing of fresh human leukaemias. Leukemia Res 1986; 10: 683-688.
5. Oshimi K, Oshimi Y, Akutsu M, Takei Y, Saito H, Okada M, Mizoguchi H. Cytotoxicity of interleukin-2-activated lymphocytes for leukemia and lymphoma cells. Blood 1986; 68: 938-948.
6. Fierro MT, Xin-Sheng L, Lusso P, Bonferroni M, Matera L, Cesano A, Lista P, Arione P, Forni G, Foa R. In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. Leukemia 1988; 2: 50-54.
7. Lotzova E, Savary CA, Herberman RB. Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors. Leukemia Res 1987; 11: 1059-1066.
8. Lista P, Fierro MT, Liao X-S, Bonferroni M, Brizzi MF, Porcu P, Pegoraro L, Foa R. Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukaemic stem cells. Eur J Haematol 1989; 42: 425-430.
9. Foa R, Caretto P, Fierro MT, Bonferroni M, Cardona S, Guarine A, Lista P, Pegoraro L, Mandelli F, Forni G. Interleukin-2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. Br J Haematol 1990; 75: 34-40.